Article 1
Open ↗Part A of the Annex to Implementing Regulation (EU) No 540/2011 is amended in accordance with the Annex to this Regulation.
Commission Implementing Regulation (EU) 2016/549 of 8 April 2016 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances bentazone, cyhalofop butyl, diquat, famoxadone, flumioxazine, DPX KE 459 (flupyrsulfuron-methyl), metalaxyl-M, picolinafen, prosulfuron, pymetrozine, thiabendazole and thifensulfuron-methyl (Text with EEA relevance)
Data as of 2026-07-04 · Compiled from an official source version. Later amendments or repeals may not be reflected; the official text prevails. · Read the official text ↗
Part A of the Annex to Implementing Regulation (EU) No 540/2011 is amended in accordance with the Annex to this Regulation.
This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union .
ANNEX Part A of the Annex to Implementing Regulation (EU) No 540/2011 is amended as follows: (1) in the sixth column, expiration of approval, of row 11, Bentazone, the date of ‘30 June 2016’ is replaced by ‘30 June 2017’; (2) in the sixth column, expiration of approval, of row 15, Diquat, the date of ‘30 June 2016’ is replaced by ‘30 June 2017’; (3) in the sixth column, expiration of approval, of row 17, Thiabendazole, the date of ‘30 June 2016’ is replaced by ‘30 June 2017’; (4) in the sixth column, expiration of approval, of row 19, DPX KE 459 (flupyrsulfuron-methyl), the date of ‘30 June 2016’ is replaced by ‘30 June 2017’; (5) in the sixth column, expiration of approval, of row 23, Pymetrozine, the date of ‘30 June 2016’ is replaced by ‘30 June 2017’; (6) in the sixth column, expiration of approval, of row 26, Thifensulfuron-methyl, the date of ‘30 June 2016’ is replaced by ‘30 June 2017’; (7) in the sixth column, expiration of approval, of row 31, Prosulfuron, the date of ‘30 June 2016’ is replaced by ‘30 June 2017’; (8) the sixth column, expiration of approval, of row 34, Cyhalofop butyl, the date of ‘30 June 2016’ is replaced by ‘30 June 2017’; (9) in the sixth column, expiration of approval, of row 35, Famoxadone, the date of ‘30 June 2016’ is replaced by ‘30 June 2017’; (10) in the sixth column, expiration of approval, of row 37, Metalaxyl-M, the date of ‘30 June 2016’ is replaced by ‘30 June 2017’; (11) in the sixth column, expiration of approval, of row 38, Picolinafen, the date of ‘30 June 2016’ is replaced by ‘30 June 2017’; (12) in the sixth column, expiration of approval, of row 39, Flumioxazine, the date of ‘30 June 2016’ is replaced by ‘30 June 2017’.
Source: EUR-Lex (Publications Office of the EU), © European Union, reuse permitted under Commission Decision 2011/833/EU.